Tracon Pharmaceuticals Secures $16,500,002 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=570bc98d-1f60-4b12-9b2a-a7f338a799c5&Preview=1 -
Date
4/1/2011 -
Company Name
Tracon Pharmaceuticals -
Mailing Address
8910 University Center Dr. San Diego, CA 92122 -
Company Description
TRACON Pharmaceuticals, Inc. is a fast growing biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis. -
Website
http://www.traconpharma.com -
Transaction Type
Venture Equity -
Transaction Amount
$16,500,002 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. Amount sold includes cash proceeds and conversion of $2,500,000 of principal/interest under certain promissory notes into equity at the purchase price paid by cash investors. Another ~$8 million in cash may be invested at the option of certain investors. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
